Clinical trials
Recruiting Cardiovascular Diseases trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
66 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 6 |
| 2024 | 13 |
| 2025 | 21 |
| 2026 | 9 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 66 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Shanghai Zhongshan Hospital | 3 |
| AstraZeneca | 2 |
| Beijing Anzhen Hospital | 2 |
| Beijing Friendship Hospital | 2 |
| Beijing Tiantan Hospital | 2 |
| China National Center for Cardiovascular Diseases | 2 |
| Chinese Academy of Medical Sciences, Fuwai Hospital | 2 |
| First Affiliated Hospital of Fujian Medical University | 2 |
| Guangdong Provincial People's Hospital | 2 |
| Jinwei Tian | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cardiovascular Diseases | 66 |
| Hypertension | 13 |
| Stroke | 7 |
| Diabetes Mellitus, Type 2 | 6 |
| Atrial Fibrillation | 5 |
| Cerebrovascular Disorders | 5 |
| Dyslipidemias | 5 |
| Heart Failure | 5 |
| Metabolic Diseases | 5 |
| Neoplasms | 5 |
Trials
Showing 1 to 25 of 66. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.